Back to Search
Start Over
Daiichi Sankyo and Merck Enter Global Development and Commercialization Agreement for MK-6070
- Source :
- Entertainment Close-up. August 26, 2024
- Publication Year :
- 2024
-
Abstract
- Daiichi Sankyo and Merck, known as MSD outside of the United States and Canada, reported they have expanded their existing global co-development and co-commercialization agreement for three investigational DXd antibody [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Entertainment Close-up
- Publication Type :
- Periodical
- Accession number :
- edsgcl.806098748